Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis
Alani O, Wang D, Wahood S, Obagi S, Dasilva D, Zirwas M, Galimberti F, Bunick C. Is Upadacitinib Cardioprotective in Chronic Inflammatory Diseases? A Review of Major Adverse Cardiovascular Events and Venous Thromboembolism in Atopic Dermatitis. Journal Of Drugs In Dermatology 2025, 24: 530-533. PMID: 40327575, DOI: 10.36849/jdd.9049.Peer-Reviewed Original ResearchConceptsUPA-treated patientsVenous thromboembolismVenous thromboembolism ratesAdverse cardiovascular eventsChronic inflammatory diseaseAtopic dermatitisMACE rateCardiovascular eventsClinical trialsInflammatory diseasesLong-term MACE rateIncidence rateImpact of upadacitinibPersistent systemic inflammationRisk of cardiovascular diseaseSystemic inflammationAD-related inflammationLower MACEBackground incidence ratesUpadacitinibJAK1 inhibitionPatientsThromboembolismCardiovascular diseaseMACE
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply